Silvy Lachance

2.0k citations
67 papers · 616 indexed · h-index 15
Topics
Hematopoietic Stem Cell Transplantation (43 papers)CAR-T cell therapy research (17 papers)Multiple Myeloma Research and Treatments (13 papers)
Partner nations
CanadaFranceGermany

In The Last Decade

Silvy Lachance

63 papers receiving 601 citations

Peers

Silvy Lachance
Comparison fields: 5 of 82
  • Hematology 331
  • Oncology 240
  • Immunology 178
  • Molecular Biology 118
  • Epidemiology 86
Replace Alice Garnier with:
Alice Garnier France
Tong Wu China
Xavier Poiré Belgium
Marie Thérèse Rubio France
Fábio R. Kerbauy Brazil
Sakhila Ghimire Germany
Mohamad Sobh France
Nathan Cantoni Switzerland
EP Smith United States
U. Gross‐Wieltsch Germany
Silvy Lachance relative to Alice Garnier France Alice Garnier's profile →
Citations per field
00.5×9.7×
Alice Garnier · 1×
Citations per year

Countries citing papers authored by Silvy Lachance

Since Specialization
Citations

This map shows the geographic impact of Silvy Lachance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvy Lachance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvy Lachance more than expected).

Fields of papers citing papers by Silvy Lachance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvy Lachance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvy Lachance. The network helps show where Silvy Lachance may publish in the future.

Co-authorship network of co-authors of Silvy Lachance

This figure shows the co-authorship network connecting the top 25 collaborators of Silvy Lachance. A scholar is included among the top collaborators of Silvy Lachance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvy Lachance. Silvy Lachance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 2
6 7
7 11
8 14
9 6
10 8
11 14
12 2
13 5
14 6
15 9
16 39
17 30
18 40
19 3
20 17

About Silvy Lachance

Silvy Lachance is a scholar working on Hematology, Transplantation and Microbiology, having authored 67 papers that have together received 616 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (43 papers), CAR-T cell therapy research (17 papers) and Multiple Myeloma Research and Treatments (13 papers). The work is most often cited by research in Hematology (331 citations), Transplantation (31 citations) and Oncology (240 citations). Silvy Lachance has collaborated with scholars based in Canada, France and Germany. Frequent co-authors include Thomas Kiss, Sandra Cohen, Jean Roy, Denis‐Claude Roy, Guy Sauvageau, Lambert Busque, Imran Ahmad, Jean‐Sébastien Delisle, Annie‐Claude Labbé and David Steffen. Their work appears in journals such as Journal of Clinical Oncology, Blood and American Journal of Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026